Can Sequencing replace traditional diagnostics in India?
Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unk
Yup—speed matters in diagnostics! 🚀 I’m working on building an automated infectious disease diagnostics lab. The goal is to take sequencing-based diagnostics mainstream.
Looking to connect with folks in clinical diagnostics and molecular biology!
I’m building a new clinical lab focused on infectious disease diagnostics powered by DNA sequencing — and would love to connect with people who have experience in:
• Runni
See More
0 replies2 likes
Nimesh Pinnamaneni
•
Helixworks Technologies • 1m
Can Sequencing replace traditional diagnostics in India?
Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unk
See More
8 replies6 likes
Chirotpal Das
Building an AI eco-s... • 3m
💡 Did you know India🇮🇳 is leading a 𝐠𝐞𝐧𝐨𝐦𝐢𝐜 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧?
The 𝐆𝐞𝐧𝐨𝐦𝐞𝐈𝐧𝐝𝐢𝐚 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 is leading the way for a genomic revolution.
What this means?
✅ 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: By developing a 𝐫
Why qPCR & Phenotypic Testing Must Be Displaced? – Part III
This is the third part of a deep dive into why qPCR & phenotypic testing need to be replaced. In Part I, I covered the limitations of current diagnostics & why incremental improvements aren
See More
0 replies2 likes
Harshajit Sarmah
Founder & Editor of ... • 2m
After selling his bootstrapped startup Wingify for $200 million, Paras Chopra is diving into artificial intelligence.
His next big project is a foundational AI research lab in India, focused on building advanced models and algorithms for the world.
BharatMed AI will be an AI-driven healthcare platform focused on early disease detection and prevention in India. Using multimodal AI, it will analyze genetics, medical imaging, wearables, and environmental factors to predict risks for diseases like
See More
7 replies3 likes
Nimesh Pinnamaneni
•
Helixworks Technologies • 1m
Why qPCR & Phenotypic Testing Must Be Displaced – Part II
If you ever want to understand the scale of a problem, look at how much it costs. Tuberculosis alone costs India, Africa, and Brazil 27 trillion INR a year in lost productivity and healthcare
See More
0 replies3 likes
Chandril Mallick
Hey I am on Medial • 6m
🚀 Seeking Funding for Innovative Health Tech Startup
I’m excited to share that I’m working on a groundbreaking health tech startup, currently at the idea stage. We aim to revolutionize patient care, diagnostics, telemedicine..
Our goal is improve
See More
1 replies6 likes
Nimesh Pinnamaneni
•
Helixworks Technologies • 1m
From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane.
💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr.
🔬 Their Truenat platform, is a battery-power
Dear Connections
I’m Sahil Bhatia, founder of an AI-driven recruitment startup revolutionizing resume screening. Our model uses machine learning and TF-IDF to rank resumes based on job relevance, eliminating manual screening inefficiencies. We aim t
